A detailed history of First Horizon Advisors, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 1,830 shares of NTRA stock, worth $312,564. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,830
Previous 2,229 17.9%
Holding current value
$312,564
Previous $241,000 3.73%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$97.75 - $129.67 $39,002 - $51,738
-399 Reduced 17.9%
1,830 $232,000
Q2 2024

Jul 19, 2024

SELL
$85.28 - $112.6 $6,907 - $9,120
-81 Reduced 3.51%
2,229 $241,000
Q1 2024

Apr 26, 2024

BUY
$59.21 - $92.9 $13,085 - $20,530
221 Added 10.58%
2,310 $211,000
Q4 2023

Feb 06, 2024

BUY
$37.55 - $62.64 $20,802 - $34,702
554 Added 36.09%
2,089 $130,000
Q3 2023

Oct 27, 2023

SELL
$43.4 - $62.52 $1,432 - $2,063
-33 Reduced 2.1%
1,535 $67,000
Q2 2023

Aug 03, 2023

SELL
$47.08 - $55.16 $1,224 - $1,434
-26 Reduced 1.63%
1,568 $76,000
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $24,867 - $39,637
680 Added 74.4%
1,594 $88,000
Q4 2022

Feb 10, 2023

SELL
$34.17 - $47.91 $3,143 - $4,407
-92 Reduced 9.15%
914 $36,000
Q3 2022

Nov 09, 2022

BUY
$36.93 - $56.68 $33,680 - $51,692
912 Added 970.21%
1,006 $44,000
Q2 2022

Aug 02, 2022

BUY
$28.13 - $44.54 $1,940 - $3,073
69 Added 276.0%
94 $3,000
Q1 2022

May 10, 2022

SELL
$30.32 - $91.33 $181 - $547
-6 Reduced 19.35%
25 $1,000
Q4 2021

Feb 09, 2022

BUY
$86.26 - $119.0 $1,725 - $2,380
20 Added 181.82%
31 $2,000
Q3 2021

Nov 15, 2021

SELL
$100.17 - $126.36 $1,402 - $1,769
-14 Reduced 56.0%
11 $1,000
Q3 2021

Nov 09, 2021

BUY
$100.17 - $126.36 $2,504 - $3,159
25 New
25 $2,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.6B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.